Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 4:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 276 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Blood Specimen Collection Clear all

Conditions: Non-Alcoholic Steatohepatitis(NASH), Hepatitis C, Hepatitis B, Fibrosis, Cirrhosis, Fatty Liver, Obesity, Childhood, Bariatric Surgery Candidate
Interventions: Not listed
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 7 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2099
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Liver Cirrhosis, Liver Cancer, HCC, Hepatocellular Carcinoma
Interventions: Multi-analyte Blood Test; Diagnostic Test
Lead sponsor: Helio Genomics; Industry
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Timeline: 2022 – 2028
U.S. locations: 7
States / cities: Escondido, California • Mission Hills, California • Gainesville, Florida + 4 more

Conditions: Head and Neck Cancers
Interventions: Not listed
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Not listed
Enrollment: 1,468 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Febrile Infection, Anthrax
Interventions: TaqMan Bacillus anthracis Detection Kit; Device
Lead sponsor: MRI Global; Industry
Eligibility: 2 Years to 89 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 3
States / cities: Tarpon Springs, Florida • Fall River, Massachusetts • Franklin, Massachusetts

Conditions: Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Lymphomatoid Granulomatosis, Leukemia-Lymphoma, Adult T-Cell
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 1,295 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Inflammatory Bowel Diseases
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 4 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Adenocarcinoma of the Breast
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Serum Analytes
Interventions: Tasso+ Serum Gel Capillary Blood Collection System; Diagnostic Test
Lead sponsor: Tasso Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Atlantis, Florida • Seattle, Washington

Conditions: Needle Stick
Interventions: Haemolance Plus safety lancet, Prolance safety lancet, MediSafe Solo safety lancet; Device
Lead sponsor: HTL-Strefa S.A.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 2
States / cities: Chicago, Illinois • Boston, Massachusetts

Conditions: Waldenstrom's Macroglobulinemia
Interventions: Bortezomib, Rituximab, Valacyclovir; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Not listed
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Healthy Volunteers
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 8 Years and older
Enrollment: 88 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pregnancy
Interventions: Not listed
Lead sponsor: Illumina, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 2,209 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 8
States / cities: Phoenix, Arizona • Hagerstown, Maryland • Greensboro, North Carolina + 5 more

Conditions: Pre-Eclampsia, Hypertension, Proteinuria in Pregnancy, Thrombocytopenia, Renal Insufficiency, Impaired Liver Function, Pulmonary Edema, Headache, Visual Impairment
Interventions: Non-interventional study; Other
Lead sponsor: Progenity, Inc.; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 344 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 24
States / cities: San Diego, California • Newark, Delaware • Boca Raton, Florida + 19 more

Conditions: Needle Stick
Interventions: ergoLance safety lancet, Acti-Lance safety lancet; Device
Lead sponsor: HTL-Strefa S.A.; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 2
States / cities: Chicago, Illinois • Boston, Massachusetts

Conditions: Hepatitis-Associated Aplastic Anemia
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 2 Years to 100 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cancer Risk
Interventions: Not listed
Lead sponsor: North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists; Other
Eligibility: 18 Years and older
Enrollment: 900,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2035
U.S. locations: 1
States / cities: Shirley, New York

Conditions: Immunity, Mucosal, Immune System Processes, Blood Specimen Collection
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: LAD-1, DOCK8, GATA2 Deficancy
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 40 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Vitamin D Deficiency
Interventions: Not listed
Lead sponsor: Fujirebio Diagnostics, Inc.; Industry
Eligibility: Not listed
Enrollment: 482 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Mountain View, California

Conditions: Blood Donors, Research Subjects, Apheresis
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer, Cancer
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Nonmalignant Neoplasm
Interventions: biologic sample preservation procedure, cytology specimen collection procedure; Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 120 Years
Enrollment: 15,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2040
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Colo-rectal Cancer, Cancer Colon, Cancer, Rectum, Neoplasms,Colorectal, Polyps, Polyp of Colon, Adenoma, Adenoma Colon
Interventions: Not listed
Lead sponsor: Freenome Holdings Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 3,275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 29
States / cities: Huntsville, Alabama • Chandler, Arizona • Tucson, Arizona + 25 more

Conditions: Alzheimer Disease
Interventions: Not listed
Lead sponsor: Banner Health; Other
Eligibility: 50 Years to 80 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Phoenix, Arizona

Search by objective public record fields.

Blood Collection Biorepository for Liver Disease Research

Multi-analyte Blood Test Clinical Trial

Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers

Febrile Whole Blood Specimen Collection and Testing

Tissue Collection for Studies of Lymph Cancer

Collection of Specimens for Study of Inflammatory Bowel Disease

Lymph Fluid and Blood Collection for Identification of Novel Biomarkers

Clinical Performance of Capillary Blood Samples Collected Using the Tasso+ Serum Gel Capillary Blood Collection System for Clinical Chemistry Testing of 14 Analytes on an Abbott Alinity Analyzer

Simulated Clinical Use Testing On Safety Lancets (Test B)

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies

A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test

Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women

Simulated Clinical Use Testing on Safety Lancets (Test A)

Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia

Clinical Biospecimen Collection

VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older

Apheresis of Patients With Immunodeficiency

Study Vitamin D in Healthy Individuals

COLLECT BLOOD/RESEARCH USE

Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test

Evaluation of a Finger Prick Collection Method for Measuring Alzheimer's Disease Blood Biomarkers